O1-3-1Safety and effectiveness of pembrolizumab monotherapy in NSCLC: Interim analysis of Japan postmarketing surveillance
Kato, Terufumi, Yamamoto, Nobuyuki, Ozaki, Masahiko, Hamada, Masahiro, Yamada, Tomoko, Kamitani, Tetsu, Kawakami, Yoshiko, Ito, Yuichiro, Hara, MitsuyoshiVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy374.002
Date:
October, 2018
File:
PDF, 96 KB
english, 2018